KBIO COMPANY Statistics
Total Valuation
KBIO COMPANY has a market cap or net worth of KRW 27.03 billion. The enterprise value is 26.05 billion.
Market Cap | 27.03B |
Enterprise Value | 26.05B |
Important Dates
The last earnings date was Thursday, March 20, 2025.
Earnings Date | Mar 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KBIO COMPANY has 115.50 million shares outstanding. The number of shares has increased by 12.62% in one year.
Current Share Class | n/a |
Shares Outstanding | 115.50M |
Shares Change (YoY) | +12.62% |
Shares Change (QoQ) | -1.16% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 77.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.35 |
PB Ratio | 0.47 |
P/TBV Ratio | 0.48 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.84 |
EV / Sales | 0.34 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -136.88 |
Financial Position
The company has a current ratio of 7.35, with a Debt / Equity ratio of 0.01.
Current Ratio | 7.35 |
Quick Ratio | 6.28 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -3.97 |
Interest Coverage | -14.23 |
Financial Efficiency
Return on equity (ROE) is -8.49% and return on invested capital (ROIC) is -0.58%.
Return on Equity (ROE) | -8.49% |
Return on Assets (ROA) | -0.53% |
Return on Invested Capital (ROIC) | -0.58% |
Return on Capital Employed (ROCE) | -1.03% |
Revenue Per Employee | 2.32B |
Profits Per Employee | -205.80M |
Employee Count | 33 |
Asset Turnover | 0.59 |
Inventory Turnover | 15.21 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.55% in the last 52 weeks. The beta is -0.32, so KBIO COMPANY's price volatility has been lower than the market average.
Beta (5Y) | -0.32 |
52-Week Price Change | -27.55% |
50-Day Moving Average | 244.94 |
200-Day Moving Average | 259.75 |
Relative Strength Index (RSI) | 47.59 |
Average Volume (20 Days) | 1,327,122 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KBIO COMPANY had revenue of KRW 76.51 billion and -6.79 billion in losses. Loss per share was -59.00.
Revenue | 76.51B |
Gross Profit | 11.66B |
Operating Income | -1.11B |
Pretax Income | -9.86B |
Net Income | -6.79B |
EBITDA | -25.92M |
EBIT | -1.11B |
Loss Per Share | -59.00 |
Balance Sheet
The company has 52.48 billion in cash and 754.97 million in debt, giving a net cash position of 51.73 billion or 447.86 per share.
Cash & Cash Equivalents | 52.48B |
Total Debt | 754.97M |
Net Cash | 51.73B |
Net Cash Per Share | 447.86 |
Equity (Book Value) | 107.08B |
Book Value Per Share | 494.34 |
Working Capital | 61.03B |
Cash Flow
In the last 12 months, operating cash flow was -119.17 million and capital expenditures -71.16 million, giving a free cash flow of -190.34 million.
Operating Cash Flow | -119.17M |
Capital Expenditures | -71.16M |
Free Cash Flow | -190.34M |
FCF Per Share | -1.65 |
Margins
Gross margin is 15.24%, with operating and profit margins of -1.45% and -8.88%.
Gross Margin | 15.24% |
Operating Margin | -1.45% |
Pretax Margin | -12.89% |
Profit Margin | -8.88% |
EBITDA Margin | -0.03% |
EBIT Margin | -1.45% |
FCF Margin | n/a |
Dividends & Yields
KBIO COMPANY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.62% |
Shareholder Yield | -12.62% |
Earnings Yield | -25.13% |
FCF Yield | -0.70% |
Stock Splits
The last stock split was on April 27, 2017. It was a reverse split with a ratio of 0.1.
Last Split Date | Apr 27, 2017 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
KBIO COMPANY has an Altman Z-Score of 2.49. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.49 |
Piotroski F-Score | n/a |